IDS. Pediatric Donor Management

Similar documents
Vitals/Hemodynamic Stability

Organ Donor Management Recommended Guidelines ADULT Brain Death (NDD)

Organ Donor Management Recommended Guidelines ADULT CARDIAC DEATH (DCD)

UPDATED Pediatric Donor Management and Dosing Guidelines

UTMB-Galveston SURGICAL INTENSIVE CARE UNIT ORGAN PROCUREMENT PROTOCOL

PEDIATRIC LIFEGIFT BRAIN DEATH PLAN

Basic Fluid and Electrolytes

LIFEGIFT BRAIN DEATH PLAN

LOOP procurement coordinators, retrieval physicians, attending physicians

POST-OP CARDIAC SURGERY PHYSICIAN S ORDER SHEET USE BALLPOINT PEN ONLY. CARDIAC INTENSIVE CARE UNIT

Faith Borunda, MSN-RN, CCRN, CPTC Senior Director of Regional Operations Southwest Transplant Alliance

General Evaluation (minimum requirements)

Hypothermia Short Set-Critical Care HYPOTHERMIA SS- CRITICAL CARE

Critical Care Treatment Guidelines

Declaring Brain Death. Ali Salim, MD Professor of Surgery Chief, Division of Trauma, Burns, Surgical Critical Care, and Emergency General Surgery

Diagnosis: Allergies:

ADULT DRUG REFERENCE Drug Indication Adult Dosage Precautions / Comments

CCRN Review - Renal. CCRN Review - Renal 10/16/2014. CCRN Review Renal. Sodium Critical Value < 120 meq/l > 160 meq/l

Titrating Critical Care Medications

2

2

DONATION AFTER CARDIAC DEATH PLAN

I have no financial disclosures

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

Diabetic Ketoacidosis (DKA) Critical Care Guideline Two Bag System

SHOCK. Emergency pediatric PICU division Pediatric Department Medical Faculty, University of Sumatera Utara H. Adam Malik Hospital

The Pharmacology of Hypotension: Vasopressor Choices for HIE patients. Keliana O Mara, PharmD August 4, 2018

Post-Cardiac Surgery Evaluation

Drug Max dose approved for IVP Dilution Rate Monitoring Parameters. Dilution not necessary (Available in prefilled syringe)

Printed copies of this document may not be up to date, obtain the most recent version from

Rounds in the ICU. Eran Segal, MD Director General ICU Sheba Medical Center

IV Fluids. I.V. Fluid Osmolarity Composition 0.9% NaCL (Normal Saline Solution, NSS) Uses/Clinical Considerations

6 th Floor and 7 East Nurses Guide Intravenous Drip List Approved for RN Administration University of Kentucky Chandler Medical Center

ADVOCATE CHRIST MEDICAL CENTER DKA (DIABETIC KETOACIDOSIS) TREATMENT GUIDELINES

DKA Adult ICU Powerplan

DIABETIC KETOACIDOSIS (DKA) K E M I A D E Y E R I, P G Y - 1

Prehospital Resuscitation for the 21 st Century Simulation Case. VF/Asystole

Vasoactive Medications. Matthew J. Korobey Pharm.D., BCCCP Critical Care Clinical Specialist Mercy St. Louis

State of Florida Hypothermia Protocol. Michael D. Weiss, M.D. Associate Professor of Pediatrics Division of Neonatology

Adult Drug Reference. Dopamine Drip Chart. Pediatric Drug Reference. Pediatric Drug Dosage Charts DRUG REFERENCES

PICU CARD SURG Post Operative Cardiac Transplant Age LESS than 6 months (Page 1 of 5)

Case Scenario 3: Shock and Sepsis

Objectives. Management of Septic Shock. Definitions Progression of sepsis. Epidemiology of severe sepsis. Major goals of therapy

FLUID MANAGEMENT AND BLOOD COMPONENT THERAPY

Surviving Sepsis Campaign Guidelines 2012 & Update for David E. Tannehill, DO Critical Care Medicine Mercy Hospital St.

Department of Pediatrics, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

Adenosine. poison/drug induced. flushing, chest pain, transient asystole. Precautions: tachycardia. fibrillation, atrial flutter. Indications: or VT

CRRT Fundamentals Pre-Test. AKI & CRRT 2017 Practice Based Learning in CRRT

Surviving Sepsis. Brian Woodcock MBChB MRCP FRCA FCCM

the bleeding won t stop? Liane Manz RN, BScN, CNCC(c) Royal Alexandra Hospital

Surviving Sepsis Campaign. Guidelines for Management of Severe Sepsis/Septic Shock. An Overview

Post Cardiac Arrest Care 2015 American Heart Association Guideline Update for CPR and Emergency Cardiovascular Care

MASSIVE TRANSFUSION DR.K.HITESH KUMAR FINAL YEAR PG DEPT. OF TRANSFUSION MEDICINE

(31189) Hypothermia Initiation Phase One

PHYSIOLOGY AND MANAGEMENT OF THE SEPTIC PATIENT

Hypothermia in Neonates with HIE TARA JENDZIO, DNP(C), RN, RNC-NIC

The Septic Patient. Dr Arunraj Navaratnarajah. Renal SpR Imperial College NHS Healthcare Trust

Contra Costa County Emergency Medical Services Drug Reference. Indication Dosing Cautions Comments

Objectives. Epidemiology of Sepsis. Review Guidelines for Resuscitation. Tx: EGDT, timing/choice of abx, activated

Level 1: Acute CHF with Hypotension (SBP < 90 torr)

WEIGHT: KG HEIGHT: CM ALLERGY CAUTION sheet reviewed Code Status Full code

Electrolytes and other equally exciting topics

R2R: Severe sepsis/septic shock. Surat Tongyoo Critical care medicine Siriraj Hospital

9/13/2015. Laboratory. HPI and PE

Date written: April 2014 Review date: April 2016 Related documents: Paediatric Sepsis 6

MASSIVE TRANSFUSION PROTOCOL

Cardiorenal and Renocardiac Syndrome

John Park, MD Assistant Professor of Medicine

DYSRHYTHMIAS. D. Assess whether or not it is the arrhythmia that is making the patient unstable or symptomatic

Introduction. Invasive Hemodynamic Monitoring. Determinants of Cardiovascular Function. Cardiovascular System. Hemodynamic Monitoring

Standardize comprehensive care of the patient with severe traumatic brain injury

Therapeutic Hypothermia for Post Cardiac Arrest Plan Initial Orders

Calcium (Ca 2+ ) mg/dl

Staging Sepsis for the Emergency Department: Physician

INTRAVENOUS FLUIDS PRINCIPLES

Therapeutic Hypothermia after Resuscitated Cardiac Arrest

ADMIT DIABETIC KETOACIDOSIS (DKA) PLAN - Phase: Begin Immediately/Emergency Center

Physician Orders ADULT: Kidney-Panc/PancTransplant Post Op Plan

Michael Avant, M.D. The Children s Hospital of GHS

HYPOVOLEMIA AND HEMORRHAGE UPDATE ON VOLUME RESUSCITATION HEMORRHAGE AND HYPOVOLEMIA DISTRIBUTION OF BODY FLUIDS 11/7/2015

INTRAVENOUS FLUID THERAPY

Printed copies of this document may not be up to date, obtain the most recent version from

7/4/2015. diffuse lung injury resulting in noncardiogenic pulmonary edema due to increase in capillary permeability

CVICU EXAM. Mrs. Jennings is a 71-year-old post-op CABG x5 with an IABP in her left femoral artery

Nitroglycerin and Heparin Drip Interfacility Protocols

WHAT DO YOU SEE WHEN YOU STIMULATE BETA

Professional Development Presents. May 2016 Medication of the Month. Milrinone Drip IN2731

Update in Critical Care Medicine

PHYSICIAN SIGNATURE DATE TIME DRUG ALLERGIES WT: KG

Case discussion. 2011/03/05 Speaker: R1 游姿寧 Supervisor: F2 黃婷韵

Sepsis is an important issue. Clinician s decision-making capability. Guideline recommendations

PICU Therapeutic Hypothermia Post Cardiac Arrest Re Warming Phase

BREAK 11:10-11:

HYPOTENSION IS DANGEROUS C. R Y A N K E A Y, M D, F A C E P 1 6 M A R C H

Sepsis: Management ANUPOL PANITCHOTE, MD. Division of Critical Care Medicine Department of Medicine, Khon Kaen University, Thailand

Acid/Base Disorders 2015

No conflicts of interest

7/4/2015. Titrating Vasoactive Drips

Resuscitation Before Emergency Surgeries FEIRAN LOU SUNY DOWNSTATE MEDICAL CENTER KINGS COUNTY HOSPITAL

COUNTY OF SACRAMENTO EMERGENCY MEDICAL SERVICES AGENCY

Transcription:

IDS Guidelines for Clinical Management of Organ Donors: Weight < 40 kg Organ Perfusion & Hormonal Replacement Guidelines: Normal HR, SBP: (see chart below) Urinary output of 1-3 cc/kg/hr CVP 6-10 mmhg Kg/lb Minimum Systolic BP Normal Heart Rates Normal Resp. Rates ET Tube Size Fluid Challenge (20 ml/kg) Premature < 2.5/5.5 40 120-170 40-60 2.5-3.0 < 50 Term 3.5/7.7 50 100-170 40-60 3.0-3.5 70 3 months 6/13.2 50 100-170 30-50 3.5 120 6 months 8/17.6 60 100-170 30-50 4.0 160 1 year 10/22 65 100-170 30-40 4.0 200 2 years 13/28.6 65 100-160 20-30 4.5 260 4 years 15/33 70 80-130 20 5.0 300 6 years 20/44 75 70-115 16 5.5 400 8 years 25/55 80 70-110 16 6.0 500 10 years 30/66 85 60-105 16 6.5 600 12 years 40/88 90 60-100 16 7.0 800 Continuous arterial pressure monitoring Continuous ECG monitoring Hourly CVP recording if available Hourly urine output Urine specific gravity at initiation of donor management and consider with the suspicion of DI Interventions: Consult pediatric intensivist/medical director Revision 0: QI/Doc Approval: KAV Page 1 of 7

Hypotension: Assess for excessive fluid losses above intake: o Output > intake and urine output < 1 ml/kg/hr o If polyuria present, refer to DI Prevention/Treatment Guideline Evaluate for evidence of recent blood loss: o Confirm that the most recent Hct is > 30% o Reaffirm w/ an immediate repeat Hct and treat per Hematology Guidelines Initiate intervention for signs of continued hemorrhage (i.e., external, GI, urinary, abdominal): consult intensivist Assess recent CVP Assess for ECG changes: o Repeat ECG and maintain at bedside o Consult MD for interpretation Assess for evidence of ongoing severe infection, drug or other allergic reactions (i.e., due to blood transfusion), pericardial effusion, or hemo/pneumothorax: o Obtain a chest radiograph o Consult MD for interpretation Discontinue medications that may contribute to hypotension (i.e., anti-hypertensives, beta-blockers) Correct intravascular volume (pre-load) = CVP > 6. Note: Take into account fluid and electrolyte status, refer to Fluid Balance and Electrolytes Guideline o Start a fluid bolus of LR or 0.9% NS at 20 ml/kg, reassess, repeat x 2 if needed: consult intensivist/medical director o Colloid solutions may be preferred for repeated fluid challenges (5% albumin: 20 ml/kg) o Maintain CVP = 6-10 Levophed (Norepinephrine) Infusion: 0.05-2 mcg/kg/min (do not exceed 2 mcg/kg/min) if so then add: o Phenylephrine infusion start at 0.1-0.5 mcg/kg/min and titrate up to maintain minimum acceptable blood pressure, maximum dose of 0.5 mcg/kg/min o Solumedrol 15 mg/kg IV over 30-60 minutes (consider repeat every 12 hrs if already given) o Consider Dopamine 2-20 mcg/kg/min o Consider Epinephrine Infusion: dose 0.1-1 mcg/kg/min o Consider Vasopressin Infusion: 0.3-2 milliunits/kg/min if urine output > 1 ml/kg/hr Consult pediatric intensivist, medical director, or transplant surgeon if higher doses of vasoactive agents are required o For a low EF (<45%), a positive inotropic agent (i.e., milrinone) should be used: consult intensivist/medical director Milrinone: dose 0.25-0.75 mcg/kg/min (no bolus, watch for vasodilation, may need alpha agonist agent) Dopamine: dose 2-20 mcg/kg/min Dobutamine: dose 2-20 mcg/kg/min Reassess: Hct, Electrolytes, and ph for correctable causes of hypotension (acidosis, anemia, and hypocalcemia should be reversed) Consider Hormone Replacement Therapy, refer to section Hormone Replacement Therapy Hormone Replacement Therapy: Improvement in cardiovascular lability Reduction in electrocardiographic abnormalities Reduction in acid-base disturbances Improvement in the suitability of organs for transplantation Revision 0: QI/Doc Approval: KAV Page 2 of 7

Reserve hormone replacement therapy for: o Unstable donors requiring dopamine at a dose of more than 10 mcg/kg/min or multiple pressors o An ejection fraction < 45% (serial echocardiograms after hormone replacement recommended) Intervention: Correct K+ > 3.5 Correct CVP > 6 Add 200 mcg T4 to 500 cc D5W or NS Give in sequential order: o Dextrose 200 mg/kg for infant/neonate or 1 gm/kg for child o 0.1 unit/kg Regular Insulin o 30 mg/kg Solumedrol over 30-60 minutes o T4 bolus then start infusion according to tables below: T4 (levothyroxine) bolus T4 (levothyroxine) infusion age mcg/kg age mcg/kg/hr 0-6 mo 5 0-6 mo 1.4 6-12 mo 4 6-12 mo 1.3 1-5 yr 3 1-5 yr 1.2 6-12 yr 2.5 6-12 yr 1 Wean vasoactive agents as able Wean T4 or DC for persistent tachycardia outside acceptable normal, or hemodynamic instability Dysrhythmia: Obtain a 12 lead ECG (STAT) Send STAT electrolytes including Ca, Mg, and Phos Supraventricular Tachycardia: o Administer Adenosine 100 mcg/kg rapid IV push for clinically significant (symptomatic BP or HR > 200. Consider fluid status and oxygenation. If no effect within 2 minutes, repeat at 200 mcg/kg (max single dose = 12 mg) o If no response within 2 minutes, consider Amiodarone 5 mg/kg infused over 5-60 minutes, may repeat dose of 5 mg/kg, then infusion at 5-15 mcg/kg/min. Monitor for hypotension: consult w/ pediatric intensivist/cardiac transplant physician/medical director prior to administering Amiodarone Other Cardiac Arrhythmias: o Consult with pediatric intensivist/medical director for treatment recommendations Fluid Balance, Glucose & Electrolyte Guidelines: Serum Na+, K+, Cl-, Mg, Ca, and Phos within normal values Urinary output of 1-3 cc/kg/hr Serum glucose 90-150 mg/dl Serum electrolyte panels every 6 hrs (if patient on an insulin drip, check blood glucose every 1 hr and serum K+ every 2 hrs) Serum K+, Ca+, Mg and Phos at initiation of management and following replacement (ideally correct to within normal limits prior to echocardiogram) Consider eliminating dextrose if there are current or potential concerns about hyperglycemia Revision 0: QI/Doc Approval: KAV Page 3 of 7

Hypoglycemia: For serum glucose < 60 mg/dl give 2 ml/kg of D10; repeat glucose check in 1 hr Consult pediatric intensivist/medical director IV Fluids: Administer maintenance IV fluids at a rate of: o 4 ml/kg for 1 st 10 kg, then o 2 ml/kg for 2 nd 10 kg, then o 1 ml/kg for every kg in weight thereafter Goal: to achieve output of 1-3 cc/kg/hr and CVP 6-8 mmhg after initial fluid resuscitation Oliguria/Polyuria: Check urine specific gravity if urine output increases or color is pale Administer DDAVP if urinary output > 5 cc/kg/hr and specific gravity is 1.005 or less AND/OR serum sodium is rising: o Infuse 0.5 mcg/hr IV o Titrate to decrease UO to 3-4 ml/kg/hr o Do not give within 4 hours of the OR Consider Vasopressin Drip: give 0.5-1 milli-units/kg/hr IV and titrate to decrease UO to 3-4 ml/kg/hr Treatment of diabetes insipidus should consist of pharmacologic management to decrease but not completely stop urine output. Replacement of urine output with ¼ or ½ normal saline should be used in conjunction with pharmacologic agent to maintain serum sodium levels between 130-150 meq/l. Administer Lasix 1 mg/kg IV push (max dose 20 mg) if urinary output < 1cc/kg/hr and SBP > minimum for age or CVP > 8 Hypernatremia: Serum Sodium Fluid Type Less than 130 D5% NS 131-140 D5% ½ NS 141-155 D5% ¼ NS 156 or greater Institute hypernatremia protocol Hypernatremia Protocol: o Calculate Fluid Volume Deficit: Current Na-Desired Na/Current Na x 1000mL/L x 0.6L/kg of body weight = ml/kg Desired Na is usually 145 unless otherwise directed by pediatric intensivist/medical director o Replace 1/2 of fluid volume deficit with 0.25% NS over 2-3 hrs (or more rapidly if the donor is hypotensive), then reassess serum sodium. If Na+ remains > 156 or not trending lower, consider repeating protocol or contact accepting liver program for guidance o Consult pediatric intensivist/medical director Hypokalemia: Note: Albuterol, Lasix, insulin, and hypothermia may depress K+ level: correct as necessary Administer KCl (adjust in cases of oliguria or polyuria) Recheck serum potassium 3 hrs after replacement complete Serum Potassium K < 3.5 KCL Replacement 0.1-0.2 meq/kg/hr (max rate 0.5 meq/kg/hr) Revision 0: QI/Doc Approval: KAV Page 4 of 7

Hyperkalemia: Consider possible causes (renal failure, excess administration of potassium) Remove all K+ from IV fluids Consider giving Lasix for diuresis (if fluid status is stable) Consider administration of dextrose, insulin, and sodium bicarbonate: consult with intensivist Re-check levels 30 minutes after every dose and replace appropriately Hypomagnesemia: Serum Magnesium Mg < 2.0 MgSo4 Replacement (max dose 2 gms) 25 mg/kg (infuse at 100 mg/min) Hypocalcemia: Assess via serum ionized calcium level Serum ionized calcium Ca < 1.2 Ca < 1.2 Calcium replacement 10-20 mg/kg of calcium chloride per central line 20-40 mg/kg of calcium gluconate Hypophosphatemia: Note: For renal insufficiency or creatinine clearance < 20, reduce replacement dosing by 50% Serum Phosphorus NaPO4 or KPO4 Replacement < 2.5 mg/dl Give 0.2 mmol/kg IV over 4-6 hrs Hematology Guidelines: Hematocrit > 30% Platelet count > 20,000 PT < 15 and PTT < 38 Obtain CBC, PT/PTT/INR at the beginning of donor management and perform a physical assessment ASAP in trauma cases where active bleeding may be a concern Interventions: Serum Blood Counts Serum Blood Type Hct < 30 Consider: 10-15 ml/kg of PRBC Platelets < 20,000 (consult liver transplant surgeon prior to infusion of any platelets) PT > 15, PTT > 38 Consider: 10-15 ml/kg FFP Consider Vitamin K if persistently elevated PT: consult with pediatric intensivist/medical director Recheck labs 1 hr after infusion and give additional treatments if necessary Keep 2 units PRBCs ahead If donor received blood transfusions prior to IDS arrival or there is active bleeding, keep 4 units ahead If donor exhibits consumption or dilutional coagulopathies and is not actively bleeding, treatment may not be necessary Note: Treatment is reserved for donors who appear to have continuing significant blood loss evidenced by: physical assessment, hemodynamic instability, changes in coagulation parameters Revision 0: QI/Doc Approval: KAV Page 5 of 7

Oxygenation & Ventilation Guidelines: Continuous SaO2 > 95%, PaO2 >100 torr, ph 7.35-7.45, pco2 30-50, FiO2 40%, PEEP 5 Continuous SaO2 oximetry monitoring ABG every 6 hrs (every 4 hrs if possible on potential lung donor), and 30 minutes after each ventilation adjustment and w/ any apparent change in function o Note: During active placement of lungs do ABGs every 3 hrs Peak inspiratory pressures with ABG (if possible lung donor) CXR on initiation of management (and every 4-6 hrs if possible on potential lung donor) o Note: CXR must be read by an MD: consultation w/ MD should be a priority For suspected pulmonary contusion, effusion, or COPD changes consider High Resolution Chest CT Oxygenation: Consider therapeutic bronchoscopy: consult with pediatric pulmonologist, if: o An O2 ABG challenge has a PO2 with < 350 torr o Donor has clinical evidence of aspiration o Suspected mucous plugs o Upon center request o Heavy oropharyngeal bleeding or drainage Use bronchodilator every 4 hrs as recommended by pediatric pulmonologist/intensivist Consider Open Lung Recruitment (if evidence of atelectasis AND hemodynamically stable) Ventilation: Adjust tidal volume and ventilation rate (see previous section) to maintain pco2 between 30-50 torr After adjusting minute ventilation, administer NaHCO3 1 meq/kg IV to correct acidosis (hypernatremia can be aggravated with repeat dosing), recheck ABG For extreme metabolic acidosis and high vasoactive requirement, ensure adequate fluid resuscitation has been given and then consider THAM (tromethamine) administration: o Base deficit x wt(kg) = mls of 0.3 molar solution of THAM Consult with pediatric intensivist for recommended best ventilator support Atelectasis: In cases with persistent or segmental atelectasis (by CXR) consider increasing PEEP Consider bronchoscopy in cases of segmental atelectasis: consult pediatric pulmonologist/intensivist Infiltrate: Consider aggressive diuresis Consider repeat Solumedrol if last dose > 12 hrs If there are effusions present, consult for consideration of a chest tube Chest PT and suction Utilize HFCWO Vest whenever possible (20 minute cycle with a 1 hr 40 minute rest); do not draw ABG within 30 minutes of vest cycle, or during percussion Note: If considering single lung transplant only position good lung up. Revision 0: QI/Doc Approval: KAV Page 6 of 7

Temperature Guidelines: Temperature: 96.8-98.6 F or 36-37 C Monitor temperature every 2 hrs Hypothermia: Apply external warming blankets, or heating devices; adjust room temperature to (76 F or 24 C) Adjust inspired air temperature on ventilator circuit between (90-98.6 F or 32-37 C) Administer all fluids and/or blood products via warming device Perform warmed NG lavage if temperature is less than (93.2 F or 34 C) Infection Guidelines: Prevention and treatment of common nosocomial infections Blood, urine and sputum cultures obtained at initiation of management Sputum gram stain (on all possible lung donors) Interventions: If already on antibiotics: o Maintain current antibiotic regimen (based off culture sensitivity) If not on antibiotics: o Administer cefazolin 25 mg/kg IV (max 2000 mg) every 8 hrs (after cultures obtained) o If potential lung donor: Administer ceftazidime 50 mg/kg IV (max 2000 mg) every 8 hrs (after cultures obtained) instead of cefazolin Consult with pediatric intensivist or pharmacist for recommendation of antibiotics to cover unit specific organisms Miscellaneous Guidelines: Spinal Reflexes: o If spinal reflexes are present, and may cause discomfort to the donor family and/or medical staff, attempt to explain the cause and effect of such reflexes o If explanations are not sufficient, consult with pediatric intensivist/medical director Revision 0: QI/Doc Approval: KAV Page 7 of 7